Search results
Results from the WOW.Com Content Network
Over-the-counter antidiarrheal drugs may be effective for some people with lymphocytic colitis. Anti-inflammatory drugs, such as salicylates, mesalazine, and systemic corticosteroids may be prescribed for people who do not respond to other drug treatment. The long-term prognosis for this disease is good with a proportion of people suffering ...
Download as PDF; Printable version; ... Lymphocytic colitis; ... Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; ...
The prognosis for lymphocytic colitis and collagenous colitis is good, and both conditions are considered to be benign. [10] The majority of people afflicted with the conditions recover from their diarrhea, and their histological abnormalities resolve, [5] although relapses commonly occur if maintenance treatment is not continued. [1] [2]
The signs and symptoms of colitis are quite variable and dependent on the cause of the given colitis and factors that modify its course and severity. [2]Common symptoms of colitis may include: mild to severe abdominal pains and tenderness (depending on the stage of the disease), persistent hemorrhagic diarrhea with pus either present or absent in the stools, fecal incontinence, flatulence ...
Collagenous colitis is an inflammatory condition of the colon.Together with the related condition lymphocytic colitis, it is a subtype of microscopic colitis, which is characterized by inflammation that specifically affects the colon (i.e. colitis), and a clinical presentation that involves watery diarrhea but a lack of rectal bleeding.
The Centers for Disease Control and Prevention is closely monitoring reports of a spike in human metapneumovirus (HMPV) in China. HMPV, which was discovered in 2001, is common but underdiagnosed ...
Grade 1 colitis does not result in any symptoms, while grade 2 colitis leads to abdominal pain, mucous and blood in the stools. Grade 3 colitis is defined by severe pain, peritoneal signs and ileus. Grade 4 colitis is defined by life-threatening consequences, including perforation, ischemia, necrosis, bleeding, or toxic megacolon.
From September 2011 to December 2012, if you bought shares in companies when Richard S. Snell joined the board, and sold them when he left, you would have a 18.7 percent return on your investment, compared to a 18.4 percent return from the S&P 500.